| 1 |
Niu W, Liu L, Wu X, Mao T, Dong Z, Wan X, Zhou H, Wang J. The features of gastric epithelial reactive hyperplastic lesions under magnifying endoscopy combined with narrow-band imaging. Scand J Gastroenterol 2023;:1-10. [PMID: 36843535 DOI: 10.1080/00365521.2023.2180314] [Reference Citation Analysis]
|
| 2 |
Liu L, Wang Y, Zhao Y, Zhang W, Liu J, Wang F, Wang P, Tang X. Global knowledge mapping and emerging trends in research between spasmolytic polypeptide-expressing metaplasia and gastric carcinogenesis: A bibliometric analysis from 2002 to 2022. Front Cell Infect Microbiol 2022;12:1108378. [PMID: 36776551 DOI: 10.3389/fcimb.2022.1108378] [Reference Citation Analysis]
|
| 3 |
Rugge M, Bricca L, Guzzinati S, Sacchi D, Pizzi M, Savarino E, Farinati F, Zorzi M, Fassan M, Dei Tos AP, Malfertheiner P, Genta RM, Graham DY. Autoimmune gastritis: long-term natural history in naïve Helicobacter pylori-negative patients. Gut 2023;72:30-8. [PMID: 35772926 DOI: 10.1136/gutjnl-2022-327827] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 4 |
L. Waldum H. Helicobacter pylori: A Bacterium Influencing and Causing Most of the Diseases in the Upper Gastrointestinal Tract. An Overview with Respect to Pathogenesis and Treatment Based on Basic Physiology. Helicobacter pylori Infection - An Up to Date on the Pathogenic Mechanisms, Diagnosis and Clinical Management [Working Title] 2022. [DOI: 10.5772/intechopen.108494] [Reference Citation Analysis]
|
| 5 |
Namasivayam V, Koh CJ, Tsao S, Lee J, Ling KL, Khor C, Lim T, Li JW, Yip BC, Hussain I, Chua TS, Toh BC, Ong HS, Wang LM, So JB, Teh M, Yeoh KG, Ang TL. Academy of Medicine, Singapore clinical guideline on endoscopic surveillance and management of gastric premalignant lesions. Ann Acad Med Singap 2022;51:417-435. [DOI: 10.47102/annals-acadmedsg.2021433] [Reference Citation Analysis]
|
| 6 |
Lee JWJ, Zhu F, Srivastava S, Tsao SK, Khor C, Ho KY, Fock KM, Lim WC, Ang TL, Chow WC, So JBY, Koh CJ, Chua SJ, Wong ASY, Rao J, Lim LG, Ling KL, Chia CK, Ooi CJ, Rajnakova A, Yap WM, Salto-Tellez M, Ho B, Soong R, Chia KS, Teo YY, Teh M, Yeoh KG. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). Gut 2022;71:854-63. [PMID: 33975867 DOI: 10.1136/gutjnl-2021-324057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 22.0] [Reference Citation Analysis]
|
| 7 |
Goldenring JR, Mills JC. Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond. Gastroenterology 2022;162:415-30. [PMID: 34728185 DOI: 10.1053/j.gastro.2021.10.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 8 |
Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
|
| 9 |
Sáenz JB. Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia's Pattern of Spread Throughout the Stomach. Front Cell Dev Biol 2021;9:741574. [PMID: 34869328 DOI: 10.3389/fcell.2021.741574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 10 |
Furihata C. Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method. Proc Jpn Acad Ser B Phys Biol Sci 2021;97:462-78. [PMID: 34629355 DOI: 10.2183/pjab.97.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Rugge M, Savarino E, Sbaraglia M, Bricca L, Malfertheiner P. Gastritis: The clinico-pathological spectrum. Dig Liver Dis 2021;53:1237-46. [PMID: 33785282 DOI: 10.1016/j.dld.2021.03.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 12 |
Waldum H, Fossmark R. Gastritis, Gastric Polyps and Gastric Cancer. Int J Mol Sci 2021;22:6548. [PMID: 34207192 DOI: 10.3390/ijms22126548] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 13 |
Zhang L, Sun B, Zhou X, Wei Q, Liang S, Luo G, Li T, Lü M. Barrett's Esophagus and Intestinal Metaplasia. Front Oncol 2021;11:630837. [PMID: 34221959 DOI: 10.3389/fonc.2021.630837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 14 |
Wada Y, Nakajima S, Kushima R, Takemura S, Mori N, Hasegawa H, Nakayama T, Mukaisho KI, Yoshida A, Umano S, Yamamoto K, Sugihara H, Murakami K. Pyloric, pseudopyloric, and spasmolytic polypeptide-expressing metaplasias in autoimmune gastritis: a case series of 22 Japanese patients. Virchows Arch 2021;479:169-78. [PMID: 33515301 DOI: 10.1007/s00428-021-03033-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Noto JM, Ferrero RL. Helicobacter pylori-induced gastric carcinogenesis. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00004-6] [Reference Citation Analysis]
|
| 16 |
Waldum H, Mjønes P. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers (Basel) 2020;12:E3477. [PMID: 33266504 DOI: 10.3390/cancers12113477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Bornschein J, Rugge M. Bright future for endoscopy: the new frontier of gastric cancer secondary prevention. Gut 2020;69:1723-4. [PMID: 32532892 DOI: 10.1136/gutjnl-2020-321570] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Waldum HL, Fossmark R. Role of Autoimmune Gastritis in Gastric Cancer. Clin Transl Gastroenterol 2019;10:e00080. [PMID: 31517647 DOI: 10.14309/ctg.0000000000000080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 19 |
Waldum HL. Clinical consequences of controversies in gastric physiology. Scand J Gastroenterol 2020;55:752-8. [PMID: 32515242 DOI: 10.1080/00365521.2020.1771758] [Reference Citation Analysis]
|
| 20 |
Engstrand L, Graham DY. Microbiome and Gastric Cancer. Dig Dis Sci 2020;65:865-73. [PMID: 32040665 DOI: 10.1007/s10620-020-06101-z] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 14.3] [Reference Citation Analysis]
|
| 21 |
Aasarød KM, Waldum HL, Stunes AK, Sandvik AK, Flatberg A, Mjønes P, Syversen U, Bakke I, Fossmark R. Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice. Int J Mol Sci 2020;21:E927. [PMID: 32023822 DOI: 10.3390/ijms21030927] [Reference Citation Analysis]
|
| 22 |
Weise F, Vieth M, Reinhold D, Haybaeck J, Goni E, Lippert H, Ridwelski K, Lingohr P, Schildberg C, Vassos N, Kruschewski M, Krasniuk I, Grimminger PP, Waidmann O, Peitz U, Veits L, Kreuser N, Lang H, Bruns C, Moehler M, Lordick F, Gockel I, Schumacher J, Malfertheiner P, Venerito M. Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research. United European Gastroenterol J 2020;8:175-84. [PMID: 32213076 DOI: 10.1177/2050640619891580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 23 |
Graham DY, Rugge M, Genta RM. Diagnosis: gastric intestinal metaplasia - what to do next? Curr Opin Gastroenterol 2019;35:535-43. [PMID: 31415250 DOI: 10.1097/MOG.0000000000000576] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 24 |
Waldum HL, Rehfeld JF. Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia. Scand J Gastroenterol 2019;54:1118-23. [PMID: 31524029 DOI: 10.1080/00365521.2019.1663446] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 25 |
Negovan A, Iancu M, Fülöp E, Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol 2019; 25(30): 4105-4124 [PMID: 31435167 DOI: 10.3748/wjg.v25.i30.4105] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 26 |
Peng C, Li NS, Hu Y, Lu NH. Impact factors that modulate gastric cancer risk in Helicobacter pylori-infected rodent models. Helicobacter 2019;24:e12580. [PMID: 30950162 DOI: 10.1111/hel.12580] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 27 |
Rugge M, Sugano K, Scarpignato C, Sacchi D, Oblitas WJ, Naccarato AG. Gastric cancer prevention targeted on risk assessment: Gastritis OLGA staging. Helicobacter 2019;24:e12571. [PMID: 30773732 DOI: 10.1111/hel.12571] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 28 |
Hata M, Hayakawa Y, Koike K. Gastric Stem Cell and Cellular Origin of Cancer. Biomedicines 2018;6:E100. [PMID: 30384487 DOI: 10.3390/biomedicines6040100] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
